Blood–brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood–central nervous system interface

DTT Phan, RHF Bender… - Experimental …, 2017 - journals.sagepub.com
The blood–brain barrier is a dynamic and highly organized structure that strictly regulates
the molecules allowed to cross the brain vasculature into the central nervous system. The …

Current challenges in glioblastoma: intratumour heterogeneity, residual disease, and models to predict disease recurrence

HP Ellis, M Greenslade, B Powell, I Spiteri… - Frontiers in …, 2015 - frontiersin.org
Glioblastoma (GB) is the most common primary malignant brain tumor, and despite the
availability of chemotherapy and radiotherapy to combat the disease, overall survival …

Mathematical formulation and parametric analysis of in vitro cell models in microfluidic devices: application to different stages of glioblastoma evolution

J Ayensa-Jiménez, M Pérez-Aliacar, T Randelovic… - Scientific Reports, 2020 - nature.com
In silico models and computer simulation are invaluable tools to better understand complex
biological processes such as cancer evolution. However, the complexity of the biological …

[HTML][HTML] The anti-angiogenic effect of atorvastatin in glioblastoma spheroids tumor cultured in fibrin gel: in 3D in vitro model

N Bayat, R Izadpanah… - Asian Pacific journal …, 2018 - ncbi.nlm.nih.gov
Purpose: Glioblastoma multiform (GBM) is the most aggressive glial neoplasm. Researchers
have exploited the fact that GBMs are highly vascularized tumors. Anti-angiogenic strategies …

Personalized radiotherapy planning based on a computational tumor growth model

M Lê, H Delingette, J Kalpathy-Cramer… - IEEE transactions on …, 2016 - ieeexplore.ieee.org
In this article, we propose a proof of concept for the automatic planning of personalized
radiotherapy for brain tumors. A computational model of glioblastoma growth is combined …

MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-β pathway

X He, Z Liu, Y Peng, C Yu - Biochemical and biophysical research …, 2016 - Elsevier
MicroRNAs (miRNAs) are small non-coding RNAs frequently dysregulated in human
malignancies. In this study, we found that miR-181c was down-regulated both in …

Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial

L Kong, J Gao, J Hu, R Lu, J Yang, X Qiu, W Hu… - Cancer …, 2019 - Springer
Background Glioblastoma (GBM) is a highly virulent tumor of the central nervous system,
with a median survival< 15 months. Clearly, an improvement in treatment outcomes is …

[HTML][HTML] Mathematical modeling of brain metastases growth and response to therapies: A review

B Ocaña-Tienda, VM Pérez-García - Mathematical Biosciences, 2024 - Elsevier
Brain metastases (BMs) are the most common intracranial tumor type and a significant
health concern, affecting approximately 10% to 30% of all oncological patients. Although …

Physiological MRI biomarkers in the differentiation between glioblastomas and solitary brain metastases

E Heynold, M Zimmermann, N Hore… - Molecular Imaging and …, 2021 - Springer
Purpose Glioblastomas (GB) and solitary brain metastases (BM) are the most common brain
tumors in adults. GB and BM may appear similar in conventional magnetic resonance …

Radiologic progression of glioblastoma under therapy—an exploratory analysis of AVAglio

M Nowosielski, BM Ellingson, OL Chinot… - Neuro …, 2018 - academic.oup.com
Background In this exploratory analysis of AVAglio, a randomized phase III clinical study that
investigated the addition of bevacizumab (Bev) to radiotherapy/temozolomide in newly …